The presence of gene amplification was determined in 66 fresh head-and-neck SCC specimens using a battery of 9 different probes. Amplification of at least one gene was found in I 2 samples (18%), of which 7 were amplified at multiple loci (58%). We observed amplifications for EGFR (10% of samples) a
TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines
β Scribed by Li Xu; Bruce J. Davidson; V. V. V. S. Murty; Rong-Guo Li; Peter G. Sacks; Pilar Garin-Chesa; Stimson P. Schantz; R. S. K. Chaganti
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 711 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background. Abnormalities in chromosome llq13 regions have been frequently found in head and neck squamous carcinoma. Recent studies indicate that the PRAD-1 (also CCNDI), which encodes cyclin D1, is a putative oncogene that is an important component of this region. Methods. DNA was extracted
## Loss of heterozygosity (LOH ) at chromosome band 10q23 occurs frequently in a wide variety of human tumors. A recently identified candidate tumor suppressor gene, PTEN located on 10q23, is mutated in multiple advanced cancers. To explore whether PTEN is associated with human squamous cell carci